C07C 63/04
Monocyclic monocarboxylic acids
C07C63/04 (Monocyclic monocarboxylic acids) appears on 150 US grants and 176 published applications in this corpus.
Search patents in C07C- Granted patents
- 150
- Published applications
- 176
- Assignees
- 135
- Inventors
- 530
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 5 |
| 2012 | 2 | 5 |
| 2013 | 3 | 5 |
| 2014 | 4 | 4 |
| 2015 | 8 | 7 |
| 2016 | 5 | 13 |
| 2017 | 6 | 15 |
| 2018 | 10 | 14 |
| 2019 | 10 | 10 |
| 2020 | 9 | 7 |
| 2021 | 13 | 14 |
| 2022 | 4 | 17 |
| 2023 | 11 | 12 |
| 2024 | 8 | 14 |
| 2025 | 14 | 11 |
| 2026 | 6 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof26 May 2026US 12,637,470 B2Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
- Cannabinoid analogs and methods for their preparation5 May 2026US 12,617,747 B2Inmed Pharmaceuticals Inc.
- Alpha-1062 for treating traumatic brain injury31 Mar 2026US 12,589,099 B2Alpha Cognition Inc.
- Pharmaceutically acceptable salts of psilocin and uses thereof10 Feb 2026US 12,545,642 B2Eleusis Therapeutics US, Inc.
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
- Quaternary ammonium compounds (qacs) and process for preparation thereof30 Jul 2026US 2026/0216116 A1
- Alpha-1062 for treating traumatic brain injury23 Jul 2026US 2026/0207617 A1Alpha Cognition Inc.
- Lsd salt crystal forms23 Jul 2026US 2026/0209229 A1Definium Therapeutics US, Inc.
- Cannabinoid analogs and methods for their preparation9 Jul 2026US 2026/0193161 A1Inmed Pharmaceuticals Inc.
Most cited
By later US patents
- Optically active liquid crystal mixtures and liquid crystal devices containing them45US 4,149,413 AThe Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Norther Ireland · 1979
- Process for producing aromatic carboxylic acid44US 6,620,966 B2Mitsubishi Gas Chemical Company, Inc. · 2003
- Salt forms of a xanthine compound44US 8,865,729 B2Boehringer Ingelheim International GmbH · 2014
- Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine34US 9,212,183 B2Boehringer Ingelheim International GmbH · 2015
- Polyimides, a process for their preparation and their use, and tetracarboxylic acids and tetracarboxylic acid derivatives25US 4,698,295 ACiba-Geigy Corporation · 1987